Portfolio

Seahorse Bioscience

Seahorse Bioscience is a leading provider of instruments and assay kits for measuring cell metabolism and bioenergetics. In the hands of leading researchers, Seahorse’s technology provides real-time bioenergetics data that illuminates cell health function and signaling and allows researchers to understand how cells are impacted by drugs. The company was acquired in 2015 by Agilent Technologies (NYSE: A) for $235M in cash.

Back

Company Profile

Seahorse Bioscience Logo
  • Founded: 2001

Flagship Partners:

  • Harry Wilcox, Chief Operating Officer & General Partner